-
6 Biotechs Still Awaiting December Catalysts
Tuesday, December 13, 2016 - 2:53pm | 608The bottom half of December will prove to be a busy one for the biotechnology sector. Below are six biotech companies with catalysts still ahead for the end of the year. Roche Holding Roche Holding Ltd. (ADR) (OTC: RHHBY)'s Genentech unit's OCREVUS's Prescription Drug User Fee Act (PDUFA) date is...